![Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com](https://m.media-amazon.com/images/I/41sUoX6JZVL._SL10_UR1600,800_CR200,50,1200,630_CLa%7C1200,630%7C41sUoX6JZVL.jpg%7C0,0,1200,630+107,79,402,402_PJAdblSocialShare-Gradientoverlay-smallasin-0to70,TopLeft,0,0_PJAdblSocialShare-AudibleLogo-Large,TopLeft,576,270_OU01_ZBLISTENING%20ON,593,216,52,500,AudibleSansMd,30,255,255,255_PJAdblSocialShare-PodcastIcon-Small,TopLeft,1094,50_ZBTargeting%20Solid%20Tumours...,106,519,48,404,AudibleSansMd,24,255,255,255.jpg)
Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com
![A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients | Business Wire A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients | Business Wire](https://mms.businesswire.com/media/20220302005008/en/1372754/5/A2_Bio_LinkedIn_Tmod_video_2022FEB23_V02_D.jpg)
A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients | Business Wire
![The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia - Williams - 2019 - Cancer - Wiley Online Library The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia - Williams - 2019 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/f3d5777f-7b54-45f4-b98e-c9259a661374/cncr.2019.125.issue-9.cover.jpg?trick=1670775280528)